Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Matteo Simonelli

22PUBLICATIONS
71CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

Sort by Publication Date:
|Apr 01, 2026
Pembrolizumab monotherapy for microsatellite instability-high or mismatch repair deficient recurrent gliomas: results from the multicohort KEYNOTE-158 study.

Capucine Baldini, Philippe A Cassier, Jean-Pierre Delord

|Oct 13, 2025
Case study: Successful full-course chemotherapy administration in a liver transplant recipient diagnosed with central nervous system World Health Organization Grade 2 IDH mutant/1p-19q co-deleted oligodendroglioma.

Angelo Dipasquale, Agnese Losurdo, Pasquale Persico

|Aug 14, 2025
Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP-005 study recurrent glioblastoma cohort.

Sun Young Rha, Eduardo Castanon, Sanjeev Gill

|Aug 07, 2025
Primary mismatch repair deficiency and Lynch syndrome in adult diffuse gliomas: A call to action.

Pasquale Persico, Angelo Dipasquale, Agnese Losurdo

|May 14, 2025
Exploring the Role of ADCs in Brain Metastases and Primary Brain Tumors: Insight and Future Directions.

Francesco Bruzzone, Chiara Barigazzi, Antonio Di Muzio

|Mar 28, 2025
Proliferation-Diffusion Modeling in Glioblastoma: Impact of Supramaximal Resection on Survival.

Maria Pia Tropeano, Zefferino Rossini, Ettore Bresciani

Pageof 4

Frequent Collaborators

10 joint publications

Pasquale Persico

8 joint publications

Angelo Dipasquale

7 joint publications

Giuseppe Lombardi

4 joint publications

Pierina Navarria

3 joint publications

Beatrice C Bono

3 joint publications

Matteo Fassan

3 joint publications

Letterio Salvatore Politi

2 joint publications

Stefano Indraccolo

2 joint publications

Daniela Cesselli

2 joint publications

Tae Min Kim

Frequent Collaborators

10 joint publications

Pasquale Persico

8 joint publications

Angelo Dipasquale

7 joint publications

Giuseppe Lombardi

4 joint publications

Pierina Navarria

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

28.0K
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on : Sep 01, 2018

8.4K
See more related videos

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

28.0K
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on : Sep 01, 2018

8.4K
See more related videos